DHR vs TLRY · P/E 39, rev $6.26B vs rev $915.5M
Danaher Corporation (DHR) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported DHR revenue for 2026-06-26 was $6.26B. Net income was $870.0M. Revenue was up 5.3% from 2026-03-27 to 2026-06-26. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
DHR currently screens at market cap $144.18B and trailing P/E 39.0. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the DHR and TLRY stock pages for the full models.
Not investment advice.